Medication info
Exome Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Exome Tablet 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›21.69mg / 1 tablet
Manufacturer / importer
Gunil Biopharm Co., Ltd.
Appearance
Pale pink, rectangular film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu*2)
Approval status
Active

MFDS item code 201902734 · Approved 2019.04.29 · Insurance code 073001470

Summary

Main use
Treatment and prevention of reflux disease, ulcers and drug-induced gastrointestinal symptoms, and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration. No dose adjustment is necessary. Since there is limited experience with administration to patients with severe renal failure, this medicine should be administered with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not receive a dose of this medicine exceeding 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents 12 years of age and older: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents 12 years of age and older: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years of age and older: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Pediatric patients under 12 years of age: There is no experience with administering this medicine to pediatric patients under 12 years of age.

Ingredients

Manufacturer
Gunil Biopharm Co., Ltd.

Efficacy & effects

Treatment and prevention of reflux disease, ulcers and drug-induced gastrointestinal symptoms, and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • benign duodenal ulcers related to Helicobacter pylori
  • peptic ulcers
  • upper gastrointestinal symptoms
  • pain
  • discomfort
  • burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis, and is effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It is also used in combination with antibiotics for the treatment of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection and helps prevent recurrence of this bacterium. It is used short-term for relieving upper gastrointestinal pain, discomfort, and burning sensation related to the use of non-steroidal anti-inflammatory drugs (NSAIDs), and is effective for the treatment and prevention of gastric ulcers and duodenal ulcers caused by NSAID use. It is applied in the treatment of Zollinger-Ellison syndrome and for maintenance therapy after preventing rebleeding of gastric ulcers and duodenal ulcers. In summary, it is widely used for the treatment and prevention of various symptoms and diseases related to gastrointestinal disorders.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to treatment with nonsteroidal anti-inflammatory drugs. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. 20 mg once daily. The treatment period is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers by intravenous administration. No dose adjustment is necessary. Since there is limited experience with administration to patients with severe renal failure, this medicine should be administered with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not receive a dose of this medicine exceeding 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents 12 years of age and older: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medicine for an additional 4 weeks. Adolescents 12 years of age and older: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years of age and older: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Pediatric patients under 12 years of age: There is no experience with administering this medicine to pediatric patients under 12 years of age.

Precautions

This medicine should not be administered to patients with a known allergy to specific ingredients or benzamidazoles or those who have experienced hypersensitivity reactions. Additionally, patients taking certain antibiotics or antiviral agents used in conjunction with this drug for the eradication of Helicobacter pylori should not be treated with this medication. It is also safest not to administer this drug to breastfeeding women or patients with a history of myocardial infarction. This medication contains the dye Erythrosine (Red 3), so patients allergic to this substance should use it with caution. Various side effects may occur during use, including headache, abdominal pain, diarrhea, skin rashes, muscle pain, and hypomagnesemia. Especially with long-term use, regular blood tests or magnesium level checks should be conducted, and if abnormal symptoms appear, consult a doctor immediately. This medication reduces gastric acid secretion, which can increase bacterial growth in the stomach and raise the risk of infection; therefore, notify healthcare personnel if diarrhea persists. Moreover, long-term high-dose use may increase the risk of fractures, so osteoporosis patients need to be cautious. This medication can interact with many other drugs, so if you are taking other medications, be sure to inform your doctor or pharmacist before use. During pregnancy, the safety of this medication is not fully established, so pregnant women should use it cautiously, and it is advisable to avoid taking it while breastfeeding. In cases of overdose, there is no specific antidote, so symptomatic treatment should be provided while monitoring closely. Store out of reach of children and do not transfer to another container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, eosinophilia and systemic symptoms drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, substernal chest pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, lingual disorders, tongue edema, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver function abnormalities, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatic polymyalgia, arthralgia, appetite loss, apathy, increased appetite, confusion, worsening depression, hypertonia, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disturbances, tremors, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, unusual olfaction, loss of taste, taste disorder, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and the storage temperature should be maintained between 1 to 30 degrees Celsius (room temperature). By storing it this way, the effectiveness of the drug can be maintained for a long time.

Appearance and packaging

Appearance

Pale pink, rectangular film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu*2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.